Beijing, China

Qianqian Gan


Average Co-Inventor Count = 8.9

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Qianqian Gan in Tumor Imaging

Introduction

Qianqian Gan is an accomplished inventor based in Beijing, China. He has made significant contributions to the field of tumor imaging through his innovative patents. With a total of two patents to his name, Gan's work focuses on the development of glucose derivatives that have potential applications in tumor treatment and diagnosis.

Latest Patents

Gan's latest patents include a benzene ring-containing glucose derivative and a Tc-labeled isonitrile-containing glucose derivative. The first patent discloses a benzene ring-containing glucose derivative that can be used in tumor treatment and diagnosis. This derivative is characterized by a complex formed with a radionuclide, enhancing its utility in medical applications. The second patent presents a Tc-labeled isonitrile-containing glucose derivative, which is notable for its stability and effectiveness in tumor imaging. This derivative is synthesized through a straightforward preparation method, making it advantageous for widespread application in the medical field.

Career Highlights

Throughout his career, Qianqian Gan has worked with prestigious institutions such as Beijing Normal University and Beijing Shihong Pharmaceutical Research Center. His research has focused on creating innovative solutions for medical challenges, particularly in the area of oncology.

Collaborations

Gan has collaborated with notable colleagues, including Junbo Zhang and Xuran Zhang. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Qianqian Gan's contributions to the field of tumor imaging through his innovative patents highlight his role as a leading inventor in medical research. His work not only advances scientific knowledge but also holds promise for improving patient outcomes in cancer treatment.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…